Eversept Partners as of June 30, 2024
Portfolio Holdings for Eversept Partners
Eversept Partners holds 74 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 9.4 | $137M | 286k | 479.11 | |
GSK Sponsored Adr (GSK) | 9.1 | $134M | 3.5M | 38.50 | |
Natera (NTRA) | 8.7 | $127M | 1.2M | 108.29 | |
Insmed Com Par $.01 (INSM) | 5.3 | $77M | 1.2M | 67.00 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 5.3 | $77M | 4.7M | 16.25 | |
United Therapeutics Corporation (UTHR) | 5.1 | $75M | 235k | 318.55 | |
Syndax Pharmaceuticals (SNDX) | 5.1 | $74M | 3.6M | 20.53 | |
Vera Therapeutics Cl A (VERA) | 5.1 | $74M | 2.0M | 36.18 | |
Inspire Med Sys (INSP) | 4.9 | $71M | 533k | 133.83 | |
PerkinElmer (RVTY) | 3.2 | $47M | 452k | 104.86 | |
Hca Holdings (HCA) | 3.0 | $44M | 136k | 321.28 | |
Bio-techne Corporation (TECH) | 2.7 | $39M | 543k | 71.65 | |
Healthequity (HQY) | 2.4 | $36M | 414k | 86.20 | |
Community Health Systems (CYH) | 1.8 | $27M | 8.0M | 3.36 | |
Repligen Corporation (RGEN) | 1.7 | $25M | 194k | 126.06 | |
Celldex Therapeutics Com New (CLDX) | 1.6 | $23M | 633k | 37.01 | |
Ionis Pharmaceuticals (IONS) | 1.5 | $22M | 457k | 47.66 | |
Novo-nordisk A S Adr (NVO) | 1.4 | $21M | 147k | 142.74 | |
Eli Lilly & Co. (LLY) | 1.3 | $19M | 21k | 905.38 | |
Protagonist Therapeutics (PTGX) | 1.2 | $18M | 506k | 34.65 | |
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 1.1 | $17M | 31k | 544.22 | |
Argenx Se Sponsored Adr (ARGX) | 1.0 | $15M | 35k | 430.04 | |
Humana (HUM) | 1.0 | $14M | 38k | 373.65 | |
Viatris (VTRS) | 1.0 | $14M | 1.3M | 10.63 | |
Zimvie (ZIMV) | 1.0 | $14M | 768k | 18.25 | |
Mannkind Corp Com New (MNKD) | 0.8 | $12M | 2.3M | 5.22 | |
Brookdale Senior Living (BKD) | 0.7 | $11M | 1.5M | 6.83 | |
Danaher Corporation (DHR) | 0.7 | $10M | 41k | 249.85 | |
Spdr Ser Tr S&p Biotech (XBI) | 0.6 | $9.3M | 100k | 92.71 | |
Travere Therapeutics (TVTX) | 0.6 | $9.0M | 1.1M | 8.22 | |
Anthem (ELV) | 0.5 | $7.9M | 15k | 541.86 | |
Arcutis Biotherapeutics (ARQT) | 0.5 | $7.8M | 838k | 9.30 | |
Centene Corporation (CNC) | 0.5 | $7.7M | 116k | 66.30 | |
Miragen Therapeutics (VRDN) | 0.5 | $7.4M | 568k | 13.01 | |
Viking Therapeutics (VKTX) | 0.5 | $7.3M | 139k | 53.01 | |
Vaxcyte (PCVX) | 0.5 | $7.3M | 96k | 75.51 | |
BioCryst Pharmaceuticals (BCRX) | 0.5 | $7.1M | 1.2M | 6.18 | |
Cytokinetics Com New (CYTK) | 0.5 | $6.9M | 127k | 54.18 | |
Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.4 | $6.3M | 330k | 19.21 | |
Evolus (EOLS) | 0.4 | $6.2M | 575k | 10.85 | |
Molina Healthcare (MOH) | 0.4 | $5.4M | 18k | 297.30 | |
Sutro Biopharma (STRO) | 0.3 | $5.1M | 1.7M | 2.93 | |
Gossamer Bio (GOSS) | 0.3 | $4.9M | 5.5M | 0.90 | |
Oscar Health Cl A (OSCR) | 0.3 | $4.9M | 311k | 15.82 | |
Cerevel Therapeutics Hldng I (CERE) | 0.3 | $4.5M | 110k | 40.89 | |
Liquidia Corporation Com New (LQDA) | 0.3 | $4.5M | 374k | 12.00 | |
Myriad Genetics (MYGN) | 0.3 | $4.5M | 182k | 24.46 | |
Puma Biotechnology (PBYI) | 0.3 | $4.3M | 1.3M | 3.26 | |
Karyopharm Therapeutics (KPTI) | 0.3 | $4.3M | 5.0M | 0.87 | |
2seventy Bio Common Stock (TSVT) | 0.3 | $4.3M | 1.1M | 3.85 | |
Nevro (NVRO) | 0.3 | $4.2M | 499k | 8.42 | |
Icon SHS (ICLR) | 0.3 | $4.0M | 13k | 313.47 | |
Merus N V (MRUS) | 0.3 | $3.9M | 67k | 59.17 | |
Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.2 | $3.1M | 72k | 43.97 | |
Amarin Corp Spons Adr New (AMRN) | 0.2 | $3.0M | 4.3M | 0.69 | |
Guardant Health (GH) | 0.2 | $2.9M | 99k | 28.88 | |
Inflarx Nv (IFRX) | 0.2 | $2.7M | 1.6M | 1.74 | |
Avantor (AVTR) | 0.2 | $2.7M | 125k | 21.20 | |
Tourmaline Bio (TRML) | 0.2 | $2.6M | 205k | 12.86 | |
Iqvia Holdings (IQV) | 0.2 | $2.6M | 12k | 211.44 | |
Alector (ALEC) | 0.2 | $2.5M | 542k | 4.54 | |
Immunovant (IMVT) | 0.2 | $2.5M | 93k | 26.40 | |
Xoma Corp Del Com New (XOMA) | 0.1 | $2.2M | 92k | 23.69 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $2.1M | 611k | 3.48 | |
Terns Pharmaceuticals (TERN) | 0.1 | $1.9M | 286k | 6.81 | |
Mereo Biopharma Group Spon Ads (MREO) | 0.1 | $1.8M | 496k | 3.60 | |
Kura Oncology (KURA) | 0.1 | $1.5M | 72k | 20.59 | |
Absci Corp (ABSI) | 0.1 | $1.0M | 326k | 3.08 | |
Fulcrum Therapeutics (FULC) | 0.1 | $948k | 153k | 6.20 | |
Affimed N V Ordinary Shs New (AFMD) | 0.1 | $907k | 167k | 5.45 | |
Stoke Therapeutics (STOK) | 0.1 | $828k | 61k | 13.51 | |
G1 Therapeutics | 0.0 | $456k | 200k | 2.28 | |
Ac Immune Sa SHS (ACIU) | 0.0 | $396k | 99k | 3.99 | |
Seres Therapeutics (MCRB) | 0.0 | $303k | 418k | 0.72 |